Patents-Review.com
ClassID:

96578 ⎘

C07J71/0005 - CPC Classification

Classification description:

Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring Oxygen-containing hetero ring

Sub-classes:
Recent Application in this class:
#1
20250333435
2025-10-30

TIMOSAPONIN COMPOUNDS

 #2
20250074936
2025-03-06

A PROCESS FOR ISOLATION OF SAPONINS UTTROSIDE B AND UTTROSIDE A FROM SOLANUM NIGRUM LINN

 #3
20240398836
2024-12-05

EPOXY STEROIDS

 #4
20240287126
2024-08-29

NOVEL SYNTHESIS OF CHOLESTEROL

 #5
20240261319
2024-08-08

ANTI-FUNGAL COMPOSITION DERIVED FROM HESPERALOE

 #6
20240067640
2024-02-29

PHENYL MALEIMIDE LINKER AGENTS

 #7
20230340012
2023-10-26

NATURAL AND SYNTHETIC COMPOUNDS FOR TREATING CANCER AND OTHER DISEASES

 #8
20230257784
2023-08-17

Method for producing biogas from waste liquid/residue after diosgenin extraction from by aluminum chloride

 #9
20230250130
2023-08-10

C4-MODIFIED OLEANOLIC ACID DERIVATIVES FOR INHIBITION OF IL-17 AND OTHER USES

 #10
20230092979
2023-03-23

Tripartite androgen receptor eliminators, methods and uses thereof

 #11
20230061432
2023-03-02

NEW TECHNOLOGY TO CONJUGATE THE TACCALONOLIDE MICROTUBULE STABILIZERS WITH LINKERS/PAYLOADS

 #12
20220402967
2022-12-22

STEROL DERIVATIVES AND PREPARATION METHOD AND USES THEREOF

 #13
20220402965
2022-12-22

STEROL ANALOGS AND USES THEREOF

 #14
20220389051
2022-12-08

Sterol derivatives and preparation method and uses thereof

 #15
20220387453
2022-12-08

Sterol derivatives and preparation method and uses thereof

 #16
20220340616
2022-10-27

Timosaponin compounds

 #17
20220267367
2022-08-25

COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF PARKINSON'S DISEASE

 #18
20220033436
2022-02-03

DERIVATIVE OF SARSASAPOGENIN, PHARMACEUTICAL COMPOSITION AND USE THEREOF

 #19
20210395296
2021-12-23

NOVEL SALTS AND POLYMORPHS OF SCY-078

 #20
20210300963
2021-09-30

Preparations of hydrophobic therapeutic agents, methods of manufacture and use thereof

 #21
20210130392
2021-05-06

Use of steroidal glycosides, pharmaceutical formulations, use of plant extracts, process for producing plant extracts and method for treating skin disorders

 #22
20210122780
2021-04-29

COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF PARKINSON'S DISEASE

 #23
20210047364
2021-02-18

Sterol derivatives and preparation method and uses thereof

 #24
20210024570
2021-01-28

Sterol derivatives and preparation method and uses thereof

 #25
20200262863
2020-08-20

PREPARATION OF DEOXYCHOLIC ACID

 #26
20200247840
2020-08-06

Furostan-3-ol derivatives as skeletal muscle hypertrophic agents

 #27
20200207753
2020-07-02

Tripartite androgen receptor eliminators, methods and uses thereof

 #28
20200199172
2020-06-25

Natural and synthetic compounds for treating cancer and other diseases

 #29
20200109163
2020-04-09

CARBONATED BEVERAGE AND METHOD FOR CARBONATION ENHANCEMENT

 #30
20200071351
2020-03-05

TACCALONOLIDE MICROTUBULE STABILIZERS

 #31
20190359648
2019-11-28

Salts and polymorphs of SCY-078

 #32
20190358252
2019-11-28

Steroid saponins with anti-cancer activity

 #33
20190256543
2019-08-22

Methods and compounds for modulating the secretion or expression of adhesion proteins or angiopoietins of cells

 #34
20190192418
2019-06-27

Processes and Compositions Obtained from the Solanum Genus of Plants

 #35
20190169224
2019-06-06

Preparations of hydrophobic therapeutic agents, methods of manufacture and use thereof

 #36
20190153024
2019-05-23

Salts and polymorphs of SCY-078

 #37
20190153022
2019-05-23

C4-modified oleanolic acid derivatives for inhibition of IL-17 and other uses

 #38
20190010184
2019-01-10

Methods for preparation of bile acids and derivatives thereof

 #39
20190008875
2019-01-10

Steroid alkaloids and compositions and kits thereof

 #40
20190002492
2019-01-03

DERIVATIVES OF ALLOPREGNANOLONE AND OF EPIALLOPREGNANOLONE AND USES THEREOF FOR TREATING A NEUROPATHOLOGICAL CONDITION

 #41
20180311265
2018-11-01

Methods and compositions for treatment of COPD diseases

 #42
20180305399
2018-10-25

Furostan-3-ol derivatives as skeletal muscle hypertrophic agents

 #43
20180305395
2018-10-25

Methods for the preparation of deoxycholic acid, and intermediates useful in the preparation of deoxycholic acid

 #44
20180237383
2018-08-23

NATURAL PRODUCT ANALOGS INCLUDING AN ANTI-INFLAMMATORY CYANOENONE PHARMACORE AND METHODS OF USE

 #45
20180171178
2018-06-21

Method for the separation of the isoprenic constituents of guayule

 #46
20180118778
2018-05-03

Cortistatin analogues and syntheses and uses thereof

 #47
20180022775
2018-01-25

Preparations of hydrophobic therapeutic agents, methods of manufacture and use thereof

 #48
20170360802
2017-12-21

Enrichment method of ergosterol peroxide from sporoderm-broken spore powder

 #49
20170355728
2017-12-14

Neuroactive 13, 17-substituted steroids as modulators for GABA type-A receptors

 #50
20170348222
2017-12-07

Processes and compositions obtained from the genus of plants

 #51
20170313739
2017-11-02

Taccalonolide microtubule stabilizers

 #52
20170267714
2017-09-21

Natural and synthetic compounds for treating cancer and other diseases

 #53
20170190733
2017-07-06

Cyclopentanoperhydrophenanthrene framework compounds and preparation method therefor

 #54
20170152285
2017-06-01

EXTRACTING METHOD OF KUGUACIN, PHARMACEUTICAL COMPOSITION COMPRISING THE KUGUACIN AND USE THEREOF

 #55
20170037079
2017-02-09

NEUROACTIVE 13, 17-SUBSTITUTED STEROIDS AS MODULATORS FOR GABA TYPE-A RECEPTORS

 #56
20170022246
2017-01-26

Natural and synthetic compounds for treating cancer and other diseases

 #57
20160317556
2016-11-03

ATP synthase inhibitors and steroid alkaloids and uses thereof as antimicrobial agents and as potentiators for aminoglycosides against pathogenic bacteria

 #58
20160207956
2016-07-21

Salts and polymorphs of SCY-078

 #59
20160159852
2016-06-09

Combination of estrogens plus antiprogestins with significant partial agonistic effect as an effective treatment of menopausal symptoms and for prevention of the occurrence of breast cancer

 #60
20160150789
2016-06-02

PROCESS TO OBTAIN AN EXTRACT FROM SOLANUM GENUS PLANTS

 #61
20160145200
2016-05-26

Natural product analogs including an anti-inflammatory cyanoenone pharmacore and methods of use

 #62
20160060290
2016-03-03

Amphiphilic compounds

 #63
20160015634
2016-01-21

Aqueous suspensions of ciclesonide for nebulisation

 #64
20150374718
2015-12-31

Zhankuic Acid A and Analogs thereof and Their Use as an Anti-Inflammatory Agent

 #65
20150307543
2015-10-29

POLYMORPH

 #66
20150152133
2015-06-04

Acylation derivatives of paridis saponins I, preparation method therefor and application thereof

 #67
20150140088
2015-05-21

SPIROSTEROID SYSTEMS ACTING AS NEUROPROTECTIVE AND ANTI-INFLAMMATORY AGENTS

 #68
20150126483
2015-05-07

Preparations of hydrophobic therapeutic agents, methods of manufacture and use thereof

 #69
20150105543
2015-04-16

SYNTHESIS

 #70
20150050367
2015-02-19

Timosaponin compounds

 #71
20150031657
2015-01-29

Sterol derivatives and preparation method and uses thereof

 #72
20150025130
2015-01-22

Sterol derivative, preparation method therefor and use thereof

 #73
20150011627
2015-01-08

Triterpenoids and compositions containing the same

 #74
20150005488
2015-01-01

PROCESS FOR THE PREPARATION OF 17-(3-HYDROXYPROPYL)-17-HYDROXYSTEROIDS

 #75
20140357868
2014-12-04

Methods for stereoselective reduction

 #76
20140357608
2014-12-04

Taccalonolide microtubule stabilizers

 #77
20140322810
2014-10-30

Natural and synthetic compounds for treating cancer and other diseases

 #78
20140249120
2014-09-04

Neuroactive 13, 17-substituted steroids as modulators for GABA type-A receptors

 #79
20140199297
2014-07-17

Triterpene glycoside and triterpene compositions and methods of using same

 #80
20130303607
2013-11-14

Triterpenoids and compositions containing the same

 #81
20130090461
2013-04-11

Compound Smilaxchinoside F

 #82
20130060024
2013-03-07

Compounds useful for treating neurodegenerative disorders

 #83
20130060023
2013-03-07

Compounds useful for treating neurodegenerative disorders

 #84
20130060022
2013-03-07

Compounds useful for treating neurodegenerative disorders

 #85
20130060021
2013-03-07

Compounds useful for treating neurodegenerative disorders

 #86
20130060020
2013-03-07

Compounds useful for treating neurodegenerative disorders

 #87
20130060019
2013-03-07

Compounds for Use in Treating Neurodegenerative Disorders, Synthesis Thereof, and Intermediates Thereto

 #88
20130060013
2013-03-07

Compounds useful for treating neurodegenerative disorders

 #89
20130035321
2013-02-07

COMPOUNDS FOR THE TREATMENT OF OCULAR CANCER

 #90
20120283450
2012-11-08

Natural product analogs including an anti-inflammatory cyanoenone pharmacore and methods of use

 #91
20120258923
2012-10-11

Bioactivity composition of

#92
20120252776
2012-10-04

C4 monomethyl triterpenoid derivatives and methods of use thereof

 #93
20120252772
2012-10-04

Cucurbitane-triterpenoid compounds, pharmaceutical composition, use and preparation method thereof

 #94
20120251492
2012-10-04

TRITERPENE DERIVATIVE AND AGENT FOR PREVENTING OR TREATING CHRONIC HEPATITIS C

 #95
20120165513
2012-06-28

Processes for isolation and purification of enfumafungin

 #96
20120130067
2012-05-24

Sterol derivatives and their synthesis and use

 #97
20120077777
2012-03-29

ngCycloartanone derivatives with anticancer activity

 #98
20110251379
2011-10-13

COMPOUNDS USEFUL FOR TREATING NEURODEGENERATIVE DISORDERS

 #99
20110190249
2011-08-04

THERAPEUTIC METHODS AND USES OF SAPOGENINS AND THEIR DERIVATIVES

 #100
20110172225
2011-07-14

Antifungal agents

 #101
20110144323
2011-06-16

AMORPHOUS AND CRYSTALLINE FORMS OF SMILAGENIN AND ITS HYDRATES

 #102
20110136750
2011-06-09

COMPOUNDS USEFUL FOR TREATING NEURODEGENERATIVE DISORDERS

 #103
20110136749
2011-06-09

COMPOUNDS USEFUL FOR TREATING NEURODEGENERATIVE DISORDERS

 #104
20110076286
2011-03-31

Methods of inhibiting unwanted cell proliferation using an antibody that binds to sonic hedgehog and inhibits hedgehog signaling

 #105
20110060140
2011-03-10

Synthesis of (+) cortistatin A and related compounds

 #106
20110054156
2011-03-03

SYNTHESIS OF TIMOSAPONIN BII

 #107
20110020931
2011-01-27

PROLIFERATION PROMOTING AGENT FOR NEURAL STEM CELLS

 #108
20110009442
2011-01-13

Methods for stereoselective reduction

 #109
20110008333
2011-01-13

Methods of treating pancreatic or liver cancer using hedgehog antagonists

 #110
20100317637
2010-12-16

Anti-hepatitis C composition and method for preparing drug for inhibiting hepatitis C viruses or treating hepatitis C

 #111
20100144689
2010-06-10

COMPOUNDS USEFUL FOR TREATING NEURODEGENERATIVE DISORDERS

 #112
20100087411
2010-04-08

SUBSTITUTED SAPOGENINS AND THEIR USE

 #113
20100048887
2010-02-25

Dehydroandrosterone analogs including an anti-inflammatory pharmacore and methods of use

 #114
20090216008
2009-08-27

METHOD FOR THE PREPARATION OF 21-HYDROXY-6,19-OXIDOPROGESTERONE (21OH-6OP)

 #115
20090012286
2009-01-08

Process for the preparation of 17-(3-hydroxypropyl)-17-hydroxysteroids

 #116
20080293682
2008-11-27

Betulinic acid derivatives

 #117
20080207576
2008-08-28

Substituted sapogenins and their use

 #118
20080194530
2008-08-14

Chemical Compounds

 #119
20080027237
2008-01-31

Processes for preparations of 9,11-epoxy steroids and intermediates useful therein

 #120
20080021004
2008-01-24

Sapogenin derivatives and their use in the treatment of cognitive dysfunction

 #121
20080009504
2008-01-10

Antifungal agents

 #122
20080004249
2008-01-03

Chemical Compounds

 #123
20070249826
2007-10-25

METHOD FOR THE PREPARATION OF 21-HYDROXY-6,19-OXIDOPROGESTERONE (21OH-6OP)

 #124
20070149491
2007-06-28

Compounds useful for treating neurodegenerative disorders

 #125
20070117783
2007-05-24

Aqueous suspensions of ciclesonide for nebulisation

 #126
20070010503
2007-01-11

Compounds useful for treating neurodegenerative disorders

 #127
20060276415
2006-12-07

5-Beta-sapogenin and pseudosapogenin derivatives and their use in the treatment of dementia

 #128
20060100184
2006-05-11

5-β-sapogenin and pseudosapogenin derivatives and their use in the treatment of dementia

 #129
20060041119
2006-02-23

Stereospecific reduction of sapogen-3-ones

 #130
20060030551
2006-02-09

Bile-acid derived compounds for enhancing oral absorption and systemic bioavailability of drugs

 #131
20050277769
2005-12-15

Method for the preparation of 21-hydroxy-6,19-oxidoprogesterone (21OH-6OP)

 #132
20050256094
2005-11-17

Processes for preparation of 9,11-epoxy steroids and intermediates useful therein

 #133
20050159594
2005-07-21

Eplerenone crystal form exhibiting enhanced dissolution rate

 #134
20050159484
2005-07-21

Medicament

 #135
20050130948
2005-06-16

Therapeutic methods and uses of sapogenins and their derivatives